| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 364.635 | 89 |
| GSM780708 | Untreated after 4 days (C2_1) | 387.819 | 90 |
| GSM780709 | Untreated after 4 days (C3_1) | 592.73 | 93 |
| GSM780719 | Untreated after 4 days (C1_2) | 357.899 | 89 |
| GSM780720 | Untreated after 4 days (C2_2) | 392.099 | 90 |
| GSM780721 | Untreated after 4 days (C3_2) | 602.284 | 93 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 411.516 | 90 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 375.594 | 89 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 271.423 | 87 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 437.335 | 91 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 358.697 | 89 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 265.561 | 86 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 425.14 | 90 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 370.319 | 89 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 374.963 | 89 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 431.729 | 90 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 396.705 | 90 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 385.283 | 90 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 469.974 | 91 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 544.718 | 92 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 371.41 | 89 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 527.834 | 92 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 477.397 | 91 |